Hydrometeorological multi-model ensemble simulations of the 4 November 2011 flash flood event in Genoa, Italy, in the framework of the DRIHM Project

The e-Science environment developed in the framework of the EU-funded DRIHM project was used to demonstrate its ability to provide relevant, meaningful hydrometeorological forecasts. This was illustrated for the tragic case of 4 November 2011, when Genoa, Italy, was flooded as the result of heavy, convective precipitation that inundated the Bisagno catchment. The Meteorological Model Bridge (MMB), an innovative software component developed within the DRIHM project for the interoperability of meteorological and hydrological models, is a key component of the DRIHM e-Science environment. The MMB allowed three different rainfall-discharge models (DRiFt, RIBS and HBV) to be driven by four mesoscale limited-area atmospheric models (WRF-NMM, WRF-ARW, Meso-NH and AROME) and a downscaling algorithm (RainFARM) in a seamless fashion. In addition to this multi-model configuration, some of the models were run in probabilistic mode, thus giving a comprehensive account of modelling errors and a very large amount of likely hydrometeorological scenarios (> 1500). The multi-model approach proved to be necessary because, whilst various aspects of the event were successfully simulated by different models, none of the models reproduced all of these aspects correctly. It was shown that the resulting set of simulations helped identify key atmospheric processes responsible for the large rainfall accumulations over the Bisagno basin. The DRIHM e-Science environment facilitated an evaluation of the sensitivity to atmospheric and hydrological modelling errors. This showed that both had a significant impact on predicted discharges, the former being larger than the latter. Finally, the usefulness of the set of hydrometeorological simulations was assessed from a flash flood early-warning perspective

A comparison of a linear and proportional hazards approach to analyse discrete longevity data in dairy cows

The objective of this study was to compare two methods for analysis of longevity in dairy cattle. The first method, currently used for routine genetic evaluation in the UK, uses a linear model to analyse lifespan, i.e. the number of lactations a cow has survived or is expected to survive. The second method was based on the concept of proportional hazard, i.e. modelling the conditional survival probability of a cow as a function of time. Comparisons were based on estimated heritabilities, ranking of estimated breeding values of sires, estimated effects of covariates used in the final models, and the distribution of residuals. The same data set, 21497 observations on the number of lactations cows had survived, was used for both analyses, even in the presence of censored observations. Cows in the data were progeny of 487 sires. Heritability estimates for lifespan or survival were approximately 0.06 for both methods, using the definition of heritability on a logarithmic scale for the proportional hazards model. Correlations between breeding values for sires were high, with absolute values ranging from 0.93 to 0.98, depending on the model fitted. It was concluded that it may be justified to use the standard Weibull model even for discrete time measures such as the number of completed lactations, but that more research is needed in the area of discrete time variates

HyMeX, a 10-year multidisciplinary program on the Mediterranean water cycle

The Mediterranean countries are experiencing important challenges related to the water cycle, including water shortages and floods, extreme winds, and ice/snow storms, that impact critically the socioeconomic vitality in the area (causing damage to property, threatening lives, affecting the energy and transportation sectors, etc.). There are gaps in our understanding of the Mediterranean water cycle and its dynamics that include the variability of the Mediterranean Sea water budget and its feedback on the variability of the continental precipitation through air–sea interactions, the impact of precipitation variability on aquifer recharge, river discharge, and soil water content and vegetation characteristics specific to the Mediterranean basin and the mechanisms that control the location and intensity of heavy precipitating systems that often produce floods. The Hydrological Cycle in Mediterranean Experiment (HyMeX) program is a 10-yr concerted experimental effort at the international level that aims to advance the scientific knowledge of the water cycle variability in all compartments (land, sea, and atmosphere) and at various time and spatial scales. It also aims to improve the processes-based models needed for forecasting hydrometeorological extremes and the models of the regional climate system for predicting regional climate variability and evolution. Finally, it aims to assess the social and economic vulnerability to hydrometeorological natural hazards in the Mediterranean and the adaptation capacity of the territories and populations therein to provide support to policy makers to cope with water-related problems under the influence of climate change, by linking scientific outcomes with related policy requirements

Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

Aim: The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores >2 might be better managed with a target-specific oral anticoagulant (NOAC). We hypothesized that in clinical practice, VKAs may be prescribed less frequently to patients with AF and SAMe-TT2R2 scores >2 than to patients with lower scores. Methods and results: We analyzed the Phase III dataset of the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF), a large, global, prospective global registry of patients with newly diagnosed AF and ≥1 stroke risk factor. We compared baseline clinical characteristics and antithrombotic prescriptions to determine the probability of the VKA prescription among anticoagulated patients with the baseline SAMe-TT2R2 score >2 and ≤ 2. Among 17,465 anticoagulated patients with AF, 4,828 (27.6%) patients were prescribed VKA and 12,637 (72.4%) patients an NOAC: 11,884 (68.0%) patients had SAMe-TT2R2 scores 0-2 and 5,581 (32.0%) patients had scores >2. The proportion of patients prescribed VKA was 28.0% among patients with SAMe-TT2R2 scores >2 and 27.5% in those with scores ≤2. Conclusions: The lack of a clear association between the SAMe-TT2R2 score and anticoagulant selection may be attributed to the relative efficacy and safety profiles between NOACs and VKAs as well as to the absence of trial evidence that an SAMe-TT2R2-guided strategy for the selection of the type of anticoagulation in NVAF patients has an impact on clinical outcomes of efficacy and safety. The latter hypothesis is currently being tested in a randomized controlled trial. Clinical trial registration: URL: https://www.clinicaltrials.gov//Unique identifier: NCT01937377, NCT01468701, and NCT01671007. © 2020 Hellenic Society of Cardiolog

Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

Aim: The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores >2 might be better managed with a target-specific oral anticoagulant (NOAC). We hypothesized that in clinical practice, VKAs may be prescribed less frequently to patients with AF and SAMe-TT2R2 scores >2 than to patients with lower scores. Methods and results: We analyzed the Phase III dataset of the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF), a large, global, prospective global registry of patients with newly diagnosed AF and 651 stroke risk factor. We compared baseline clinical characteristics and antithrombotic prescriptions to determine the probability of the VKA prescription among anticoagulated patients with the baseline SAMe-TT2R2 score >2 and 64 2. Among 17,465 anticoagulated patients with AF, 4,828 (27.6%) patients were prescribed VKA and 12,637 (72.4%) patients an NOAC: 11,884 (68.0%) patients had SAMe-TT2R2 scores 0-2 and 5,581 (32.0%) patients had scores >2. The proportion of patients prescribed VKA was 28.0% among patients with SAMe-TT2R2 scores >2 and 27.5% in those with scores 642. Conclusions: The lack of a clear association between the SAMe-TT2R2 score and anticoagulant selection may be attributed to the relative efficacy and safety profiles between NOACs and VKAs as well as to the absence of trial evidence that an SAMe-TT2R2-guided strategy for the selection of the type of anticoagulation in NVAF patients has an impact on clinical outcomes of efficacy and safety. The latter hypothesis is currently being tested in a randomized controlled trial. Clinical trial registration: URL: https://www.clinicaltrials.gov//Unique identifier: NCT01937377, NCT01468701, and NCT01671007